Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.41 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.41 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | PTPRC | P08575 | 2/20 | 0.36 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.36 |
| ▸ | PPARA | Q07869 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14702056 | 0.94 | CA12 (0.49) | L3MBTL1LMNACA12CA14CA2 | |
| SCHEMBL10119661 | 0.94 | CA12 (0.49) | L3MBTL1LMNACA12CA14CA2 | |
| SCHEMBL15216619 | 0.94 | L3MBTL1 (0.43) | L3MBTL1TSHRALDH1A1LMNAPABPC1 | |
| SCHEMBL19295680 | 0.91 | L3MBTL1 (0.48) | L3MBTL1TSHRALDH1A1LMNAPABPC1 | |
| SCHEMBL10119667 | 0.86 | L3MBTL1 (0.47) | L3MBTL1LMNACA12CA14CA2 | |
| SCHEMBL10119660 | 0.86 | L3MBTL1 (0.47) | L3MBTL1LMNACA12CA14CA2 | |
| SCHEMBL19295676 | 0.84 | L3MBTL1 (0.48) | L3MBTL1TSHRALDH1A1LMNAPABPC1 | |
| SCHEMBL10119673 | 0.84 | CA12 (0.54) | L3MBTL1TSHRALDH1A1LMNACA12 | |
| SCHEMBL19295673 | 0.84 | TSHR (0.44) | L3MBTL1TSHRALDH1A1LMNAPABPC1 | |
| SCHEMBL28709667 | 0.82 | TSHR (0.58) | L3MBTL1TSHRALDH1A1LMNAPABPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-9598359-B2 | Sulfonates from natural oil metathesis | STEPAN COMPANY (US) | 2017-03-21 | — | — | US | disclosed |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2015-04-02 | — | — | US | disclosed |
| WO-2013162924-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130225473-A1 | SULFONATES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225473-A1 | SULFONATES FROM NATURAL OIL METATHESIS | STS, SULT1E1, SULT1A1 | L3MBTL1 2000/4885TSHR 3328/4885ALDH1A1 831/4885 |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | HHAT, AADAT, SQLE | L3MBTL1 2343/4885TSHR 3042/4885ALDH1A1 2198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.